For K-Ras-induced lung tumorigenesis in genetically engineered mouse models, Hollander et al. showed that only a deletion of Akt1 inhibited tumor initiation and progression, whereas Akt2 was not essential for tumor formation. This evidence concerns the gene KRAS and neoplasm.